Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
What are the risks of treating locally advanced pancreatic cancer with chemoradiation with duodenal stent in place due to malignant obstruction?
Is there increased toxicity in patients with duodenal stents receiving RT?
Answer from: Radiation Oncologist at Academic Institution
There is no increased risk from radiation treatment when a duodenal stent is in place.
Sign In
or
Register
to read more
11732
Related Questions
How do you manage oxaliplatin-induced splenomegaly?
How would you manage a patient with de novo oligometastatic anal cancer with a single metastasis in the pubic bone?
Would you consider SBRT for fibrolamellar HCC that is inoperable?
How would you treat a patient with synchronous node positive prostate cancer (T3bN1M0) and oligometastatic rectosigmoid cancer (T4aN1M1) with a solitary liver metastasis?
Would you alter your approach in using neoadjuvant radiation for a rectal cancer patient who has had a prior radical prostatectomy but no prior pelvic radiation?
How do you counsel a young man receiving EBRT as part of TNT for rectal cancer about risk of infertility?
Would you recommend adjuvant radiotherapy in addition to chemotherapy in gastric adenocarcinoma s/p gastrectomy with a distal positive resection margin?
What if any, is your radiation approach to treating hepatic metastases abutting/invading luminal GI structures?
What are your institutions' preferences on SBRT vs. histotripsy for treatment of liver metastases?
In a patient with pancreatic cancer who is heterozygous for the ATM c.875C>T (Pro292Leu) mutation with functional impairment in the gene product, is there any data or recommendation to support using SBRT vs. chemo-RT?